• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Infectious Disease

H1N1 vaccine likely safe for pregnant mothers

byJordan AndersonandAndrew Bishara
May 30, 2014
in Infectious Disease, Obstetrics, Public Health
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD

1. Pregnant mothers vaccinated with the MF59 A/H1N1 vaccine showed no differences in spontaneous delivery, post-partum intensive care admission, perinatal death, or low-birth weight.

2. Mothers vaccinated were found to be at slightly higher risk for eclampsia and gestational diabetes.

Evidence Rating Level: 2 (Good)

Study Rundown: In 2009 the A/H1N1 influenza strain reached pandemic status and placed an increased risk on birth outcomes. To reduce these unprecedented risks, many national health services (including Italy) altered vaccination recommendations, advising mothers in the second and third trimester to be vaccinated. This cohort study investigates the role of the MF59 A/H1N1 adjuvant influenza vaccine on birth outcomes between October 2009 and September 2010. During the study, researchers found no significant differences between vaccinated (n=6,131) and unvaccinated (n=23,987) populations when looking at spontaneous deliveries, post-partum intensive care admissions, perinatal deaths, or low-birth weight.  The study controlled for potential confounding variables such as socioeconomic status, but was unable to control for smoking history, alcohol use, or BMI. Researchers conclude that this evidence adds to a growing body of literature suggesting the MF59 influenza vaccine is safe for use during pregnancy. It should be noted that meta-analysis of published studies would provide further evidence.

Click to read the study in BMJ

RELATED REPORTS

Variable homicide mortality rates among women aged 15-44 years depending on state abortion policy

Earlier menopause is associated with faster cognitive decline and greater late-life brain changes

Relevant Reading: H1N1 2009 influenza virus infection during pregnancy in the USA

FDA approvedFor influenza: mFlusiva (Influenza Vaccine, mRNA), Aug 5, 2026→

In-Depth [cohort study]: This cohort study was focused on a population of eligible pregnancies in the Lombardy region of Italy, where the MF59 vaccine was exclusively distributed by the Italian National Health Service. Within the vaccinated cohort of pregnant mothers, 57.9% (n=3,615) were vaccinated in their third trimester, while 40.9% (n=2,557) were vaccinated in their second trimester. Analyzing the primary outcomes in the study, researchers found negligible differences between vaccinated and control populations when looking at spontaneous deliveries (odds ratio 1.02, 0.96 to 1.08), post-partum intensive care admissions (0.95, 0.47 to 1.88), perinatal deaths (1.06, 0.65 to 1.71), or low-birth weight (0.95, 0.86 to 1.04). However, the vaccinated maternal population was found to have a slightly higher risk of eclampsia (odds ratio 1.19, 1.04 to 1.39) and gestational diabetes (1.26, 1.04 to 1.53).

More from this author: Medicaid beneficiaries among most frequent visitors to the emergency department; Emerging coronavirus found to spread in healthcare facilities; CT scans linked to cancer risk in children;Slowdown in healthcare costs linked to economic and clinical factors

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

 

Tags: Influenza vaccinepregnantsafetystrainsvaccinewomen
Previous Post

Most comprehensive study to date reveals climbing worldwide obesity prevalence

Next Post

Captopril mitigates radiation-induced lung fibrosis in rats

RelatedReports

Collage of torn-gray map pieces with orange route from left to a doorway on the right, over a dark backdrop; scales of justice at top; '2 Minute Medicine' logo in bottom right.
Obstetrics

Variable homicide mortality rates among women aged 15-44 years depending on state abortion policy

October 21, 2026
An illustration showing a brain scan alongside a human brain, symbolizing brain health and cognitive decline.
Longevity

Earlier menopause is associated with faster cognitive decline and greater late-life brain changes

October 5, 2026
Two children standing on a colorful abstract background, symbolizing growth and development, possibly related to fertility or reproductive health.
Endocrinology

A long-term gonadotropin-releasing hormone agonist protocol may be associated with increased positive pregnancy outcomes in women with endometriosis undergoing frozen embryo transfer

October 1, 2026
Two vaccine vials on a balance scale, with graphic representations of viruses in the background, symbolizing vaccines for infectious diseases.
Emergency

The rotavirus vaccine (ROTASIIL) may reduce the incidence of hospitalization for rotavirus gastroenteritis in children

September 21, 2026
Next Post
Ambrisentan found ineffective against idiopathic pulmonary fibrosis

Captopril mitigates radiation-induced lung fibrosis in rats

Chemoembolization comparable to standard-of-care for small hepatocellular cancers

Combined lenalidomide and rituximab dose escalation found to be safe for CLL

Combined lenalidomide and rituximab dose escalation found to be safe for CLL

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early mitral valve surgery may improve long-term survival in asymptomatic severe mitral regurgitation
  • CDC reports increasing early-season influenza activity and at least 900 deaths nationwide
  • A concentrated exposure therapy intervention may be more effective than digital cognitive behavioural therapy in obsessive-compulsive disorder
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.